naringenin and Acute Myelogenous Leukemia

naringenin has been researched along with Acute Myelogenous Leukemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, X; Du, X; Li, M; Lou, J; Shi, D; Xu, Y; Zhang, X; Zhuo, J	1

Other Studies

1 other study(ies) available for naringenin and Acute Myelogenous Leukemia

Article	Year
Co-treatment of THP-1 cells with naringenin and curcumin induces cell cycle arrest and apoptosis via numerous pathways. Molecular medicine reports, 2015, Volume: 12, Issue:6 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Survival; Curcumin; Extracellular Signal-Regulated MAP Kinases; Flavanones; Humans; Leukemia, Myeloid, Acute; MAP Kinase Kinase 4; Proto-Oncogene Proteins c-akt; Signal Transduction; Tumor Suppressor Protein p53	2015

Article

Year

Co-treatment of THP-1 cells with naringenin and curcumin induces cell cycle arrest and apoptosis via numerous pathways.

Molecular medicine reports, 2015, Volume: 12, Issue:6

Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Survival; Curcumin; Extracellular Signal-Regulated MAP Kinases; Flavanones; Humans; Leukemia, Myeloid, Acute; MAP Kinase Kinase 4; Proto-Oncogene Proteins c-akt; Signal Transduction; Tumor Suppressor Protein p53

2015